Federica Fogacci (F Fogacci)

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 82

Top Topics

Cardiovascular Disease

Top Venues

Journal of clinical medicine

Phytotherapy research : PTR

This page only lists publications with an associated author ORCID identifier.

Publications

Federica Fogacci, Naif Saad ALGhasab, Valentina Di Micoli, Marina Giovannini, Arrigo Francesco Giuseppe Cicero
Cholesterol-Lowering Bioactive Foods and Nutraceuticals in Pediatrics: Clinical Evidence of Efficacy and Safety. Nutrients 16 (10) (2024)
Federica Fogacci, Valentina Di Micoli, Pierre Sabouret, Marina Giovannini, Arrigo Francesco Giuseppe Cicero
Lifestyle and Lipoprotein(a) Levels: Does a Specific Counseling Make Sense? Journal of clinical medicine 13 (3) (2024)
Barbara Pala, Laura Pennazzi, Giulia Nardoianni, Federica Fogacci, Arrigo Francesco Giuseppe Cicero, Laura Di Renzo, Emanuele Barbato, Giuliano Tocci
Gut Microbiota Dysbiosis and Sleep Disorders: Culprit in Cardiovascular Diseases. Journal of clinical medicine 13 (11) (2024)
Federica Fogacci, Marina Giovannini, Giuliano Tocci, Egidio Imbalzano, Claudio Borghi, Arrigo Francesco Giuseppe Cicero
Effect of Coenzyme Q 10 on Physical Performance in Older Adults with Statin-Associated Asthenia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. Journal of clinical medicine 13 (13) (2024)
Angela Punzo, Alessia Silla, Federica Fogacci, Matteo Perillo, Arrigo Francesco Giuseppe Cicero, Cristiana Caliceti
Bile Acids and Bilirubin Role in Oxidative Stress and Inflammation in Cardiovascular Diseases. Diseases (Basel, Switzerland) 12 (5) (2024)
Federica Fogacci, Marina Giovannini, Valentina Di Micoli, Elisa Grandi, Claudio Borghi, Arrigo Francesco Giuseppe Cicero
Effect of Supplementation of a Butyrate-Based Formula in Individuals with Liver Steatosis and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Nutrients 16 (15) (2024)
Federica Fogacci, Marina Giovannini, Antonio Di Micoli, Giulia Fiorini, Elisa Grandi, Claudio Borghi, Arrigo Francesco Giuseppe Cicero
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Effect of a Dietary Supplement Containing Dry Artichoke and Bergamot Extracts on Metabolic and Vascular Risk Factors in Individuals with Suboptimal Cholesterol Levels. Nutrients 16 (11) (2024)
Arrigo Francesco Giuseppe Cicero, Naif Saad ALGhasab, Giuliano Tocci, Giovambattista Desideri, Giulia Fiorini, Federica Fogacci
Efficacy and Safety of Low-Dose Bisoprolol/Hydrochlorothiazide Combination for the Treatment of Hypertension: A Systematic Review and Meta-Analysis. Journal of clinical medicine 13 (15) (2024)
Federica Fogacci, Naif Saad ALGhasab, Valentina Di Micoli, Marina Giovannini, Arrigo Francesco Giuseppe Cicero
Cholesterol-Lowering Bioactive Foods and Nutraceuticals in Pediatrics: Clinical Evidence of Efficacy and Safety. Nutrients 16 (10) (2024)
Barbara Pala, Laura Pennazzi, Giulia Nardoianni, Federica Fogacci, Arrigo Francesco Giuseppe Cicero, Laura Di Renzo, Emanuele Barbato, Giuliano Tocci
Gut Microbiota Dysbiosis and Sleep Disorders: Culprit in Cardiovascular Diseases. Journal of clinical medicine 13 (11) (2024)
Federica Fogacci, Marina Giovannini, Antonio Di Micoli, Giulia Fiorini, Elisa Grandi, Claudio Borghi, Arrigo Francesco Giuseppe Cicero
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Effect of a Dietary Supplement Containing Dry Artichoke and Bergamot Extracts on Metabolic and Vascular Risk Factors in Individuals with Suboptimal Cholesterol Levels. Nutrients 16 (11) (2024)
Federica Fogacci, Marina Giovannini, Valentina Di Micoli, Elisa Grandi, Claudio Borghi, Arrigo Francesco Giuseppe Cicero
Effect of Supplementation of a Butyrate-Based Formula in Individuals with Liver Steatosis and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Nutrients 16 (15) (2024)
Arrigo Francesco Giuseppe Cicero, Naif Saad ALGhasab, Giuliano Tocci, Giovambattista Desideri, Giulia Fiorini, Federica Fogacci
Efficacy and Safety of Low-Dose Bisoprolol/Hydrochlorothiazide Combination for the Treatment of Hypertension: A Systematic Review and Meta-Analysis. Journal of clinical medicine 13 (15) (2024)
Federica Fogacci, Marina Giovannini, Giuliano Tocci, Egidio Imbalzano, Claudio Borghi, Arrigo Francesco Giuseppe Cicero
Effect of Coenzyme Q 10 on Physical Performance in Older Adults with Statin-Associated Asthenia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. Journal of clinical medicine 13 (13) (2024)
Federica Fogacci, Naif Saad ALGhasab, Valentina Di Micoli, Marina Giovannini, Arrigo Francesco Giuseppe Cicero
Cholesterol-Lowering Bioactive Foods and Nutraceuticals in Pediatrics: Clinical Evidence of Efficacy and Safety. Nutrients 16 (10) (2024)
Angela Punzo, Alessia Silla, Federica Fogacci, Matteo Perillo, Arrigo Francesco Giuseppe Cicero, Cristiana Caliceti
Bile Acids and Bilirubin Role in Oxidative Stress and Inflammation in Cardiovascular Diseases. Diseases (Basel, Switzerland) 12 (5) (2024)
Federica Fogacci, Valentina Di Micoli, Pierre Sabouret, Marina Giovannini, Arrigo Francesco Giuseppe Cicero
Lifestyle and Lipoprotein(a) Levels: Does a Specific Counseling Make Sense? Journal of clinical medicine 13 (3) (2024)
Giuseppe Annunziata, Massimiliano Caprio, Ludovica Verde, A M Carella, Elisabetta Camajani, A Benvenuto, Barbara Paolini, Luca De Nicola, Filippo Aucella, Vincenzo Bellizzi, S Barberi, Davide Grassi, Federica Fogacci, Annamaria Colao, Arrigo Francesco Giuseppe Cicero, Flavia Prodam, Gianluca Aimaretti, Giovanna Muscogiuri, Luigi Barrea
Nutritional assessment and medical dietary therapy for management of obesity in patients with non-dialysis chronic kidney disease: a practical guide for endocrinologist, nutritionists and nephrologists. A consensus statement from the Italian society of endocrinology (SIE), working group of the club nutrition-hormones and metabolism; the Italian society of nutraceuticals (SINut), club ketodiets and nutraceuticals "KetoNut-SINut"; and the Italian society of nephrology (SIN). Journal of endocrinological investigation (2024)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Marina Giovannini, Elisa Grandi, Sergio D'Addato, Claudio Borghi
Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting. Biomedicines 11 (12) (2023)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Valentina Di Micoli, Cristina Angeloni, Marina Giovannini, Claudio Borghi
Purine Metabolism Dysfunctions: Experimental Methods of Detection and Diagnostic Potential. International journal of molecular sciences 24 (8) (2023)
Maria Pierdomenico, Arrigo Francesco Giuseppe Cicero, Maddalena Veronesi, Federica Fogacci, Costanza Riccioni, Barbara Benassi
Effect of Citrus bergamia extract on lipid profile: A combined in vitro and human study. Phytotherapy research : PTR (2023)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Marina Giovannini, Elisa Grandi, Sergio D'Addato, Claudio Borghi
Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting. Biomedicines 11 (12) (2023)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Valentina Di Micoli, Cristina Angeloni, Marina Giovannini, Claudio Borghi
Purine Metabolism Dysfunctions: Experimental Methods of Detection and Diagnostic Potential. International journal of molecular sciences 24 (8) (2023)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Sergio D'Addato, Elisa Grandi, Elisabetta Rizzoli, Claudio Borghi, null On Behalf Of The Brisighella Heart Study
Self-Reported Coffee Consumption and Central and Peripheral Blood Pressure in the Cohort of the Brisighella Heart Study. Nutrients 15 (2) (2023)
Federica Fogacci, Valentina Di Micoli, Ashot Avagimyan, Marina Giovannini, Egidio Imbalzano, Arrigo Francesco Giuseppe Cicero
Assessment of Apolipoprotein(a) Isoform Size Using Phenotypic and Genotypic Methods. International journal of molecular sciences 24 (18) (2023)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Claudio Borghi
An Evolving Definition of a "Healthy Diet". Nutrients 15 (9) (2023)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Sergio D'Addato, Elisa Grandi, Elisabetta Rizzoli, Claudio Borghi, null On Behalf Of The Brisighella Heart Study
Self-Reported Coffee Consumption and Central and Peripheral Blood Pressure in the Cohort of the Brisighella Heart Study. Nutrients 15 (2) (2023)
Federica Fogacci, Serra İlayda Yerlitaş, Marina Giovannini, Gökmen Zararsız, Paolo Lido, Claudio Borghi, Arrigo Francesco Giuseppe Cicero
Sex X Time Interactions in Lp(a) and LDL-C Response to Evolocumab. Biomedicines 11 (12) (2023)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Sergio D'Addato, Elisa Grandi, Elisabetta Rizzoli, Claudio Borghi, null On Behalf Of The Brisighella Heart Study
Self-Reported Coffee Consumption and Central and Peripheral Blood Pressure in the Cohort of the Brisighella Heart Study. Nutrients 15 (2) (2023)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Sergio D'Addato, Elisa Grandi, Elisabetta Rizzoli, Claudio Borghi, null On Behalf Of The Brisighella Heart Study
Self-Reported Coffee Consumption and Central and Peripheral Blood Pressure in the Cohort of the Brisighella Heart Study. Nutrients 15 (2) (2023)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Anca Mihaela Pantea Stoian, Peter P Toth
Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review. Nutrients 15 (10) (2023)
Cormac Kennedy, Peter Hayes, Sulafa Salama, Martina Hennessy, Federica Fogacci
The Effect of Semaglutide on Blood Pressure in Patients without Diabetes: A Systematic Review and Meta-Analysis. Journal of clinical medicine 12 (3) (2023)
Alessia Silla, Federica Fogacci, Angela Punzo, Silvana Hrelia, Patrizia Simoni, Cristiana Caliceti, Arrigo Francesco Giuseppe Cicero
Treatment with PCSK9 Inhibitor Evolocumab Improves Vascular Oxidative Stress and Arterial Stiffness in Hypercholesterolemic Patients with High Cardiovascular Risk. Antioxidants (Basel, Switzerland) 12 (3) (2023)
Francesco Perone, Marco Bernardi, Alban Redheuil, Dario Mafrica, Edoardo Conte, Luigi Spadafora, Fiona Ecarnot, Lale Tokgozoglu, Carlos G Santos-Gallego, Sergio Emanuel Kaiser, Federica Fogacci, Annabelle Sabouret, Deepak L Bhatt, Francesco Paneni, Maciej Banach, Raul Santos, Giuseppe Biondi Zoccai, Kausik K Ray, Pierre Sabouret
Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future Directions. Journal of clinical medicine 12 (17) (2023)
Federica Fogacci, Serra İlayda Yerlitaş, Marina Giovannini, Gökmen Zararsız, Paolo Lido, Claudio Borghi, Arrigo Francesco Giuseppe Cicero
Sex X Time Interactions in Lp(a) and LDL-C Response to Evolocumab. Biomedicines 11 (12) (2023)
Federica Fogacci, Daniela Degli Esposti, Antonio Di Micoli, Giulia Fiorini, Maddalena Veronesi, Claudio Borghi, Arrigo Francesco Giuseppe Cicero
Effect of dietary supplementation with Diuripres® on blood pressure, vascular health, and metabolic parameters in individuals with high-normal blood pressure or stage I hypertension: The CONDOR randomized clinical study. Phytotherapy research : PTR (2023)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Marina Giovannini, Elisabetta Rizzoli, Elisa Grandi, Sergio D'Addato, Claudio Borghi
The Effect of Dietary Supplementation with Plant Sterols on Total and LDL-Cholesterol in Plasma Is Affected by Adherence to Mediterranean Diet: Insights from the DESCO Randomized Clinical Study. Nutrients 15 (21) (2023)
Alessia Silla, Federica Fogacci, Angela Punzo, Silvana Hrelia, Patrizia Simoni, Cristiana Caliceti, Arrigo Francesco Giuseppe Cicero
Treatment with PCSK9 Inhibitor Evolocumab Improves Vascular Oxidative Stress and Arterial Stiffness in Hypercholesterolemic Patients with High Cardiovascular Risk. Antioxidants (Basel, Switzerland) 12 (3) (2023)
Cormac Kennedy, Peter Hayes, Sulafa Salama, Martina Hennessy, Federica Fogacci
The Effect of Semaglutide on Blood Pressure in Patients without Diabetes: A Systematic Review and Meta-Analysis. Journal of clinical medicine 12 (3) (2023)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Valentina Di Micoli, Cristina Angeloni, Marina Giovannini, Claudio Borghi
Purine Metabolism Dysfunctions: Experimental Methods of Detection and Diagnostic Potential. International journal of molecular sciences 24 (8) (2023)
Cormac Kennedy, Peter Hayes, Sulafa Salama, Martina Hennessy, Federica Fogacci
The Effect of Semaglutide on Blood Pressure in Patients without Diabetes: A Systematic Review and Meta-Analysis. Journal of clinical medicine 12 (3) (2023)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Giuseppe Derosa, Angela D'Angelo, Fulvio Ventura, Elisabetta Rizzoli, Sergio D'Addato, Claudio Borghi, null On Behalf Of The Brisighella Heart Study Group
Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study. Biomedicines 10 (3) (2022)
Federica Fogacci, Marina Giovannini, Elisa Grandi, Egidio Imbalzano, Daniela Degli Esposti, Claudio Borghi, Arrigo Francesco Giuseppe Cicero
Management of High-Risk Hypercholesterolemic Patients and PCSK9 Inhibitors Reimbursement Policies: Data from a Cohort of Italian Hypercholesterolemic Outpatients. Journal of clinical medicine 11 (16) (2022)
Davide Agnoletti, Federica Fogacci, Antonio Di Micoli, Claudio Borghi, Arrigo Francesco Giuseppe Cicero
A case of liver injury during lipid-lowering therapy. Phytotherapy research : PTR 36 (11) (2022)
Arrigo F G Cicero, Federica Fogacci, Alessio Bragagni, Claudio Borghi
Short-term evolocumab-induced tendon xanthomas regression in an elderly patient with homozygous familial hypercholesterolemia. Internal and emergency medicine (2022)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Elisabetta Rizzoli, Sergio D'Addato, Claudio Borghi, null null
Correction: Cicero et al. Long-Term Impact of Different Triple Combination Antihypertensive Medications on Blood Pressure Control, Metabolic Pattern and Incident Events: Data from the Brisighella Heart Study. J. Clin. Med. 2021, 10 , 5921. Journal of clinical medicine 11 (23) (2022)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Elisabetta Rizzoli, Sergio D'Addato, Claudio Borghi, null null
Correction: Cicero et al. Long-Term Impact of Different Triple Combination Antihypertensive Medications on Blood Pressure Control, Metabolic Pattern and Incident Events: Data from the Brisighella Heart Study. J. Clin. Med. 2021, 10 , 5921. Journal of clinical medicine 11 (23) (2022)
Federica Fogacci, Elisabetta Rizzoli, Marina Giovannini, Marilisa Bove, Sergio D'Addato, Claudio Borghi, Arrigo Francesco Giuseppe Cicero
Effect of Dietary Supplementation with Eufortyn ® Colesterolo Plus on Serum Lipids, Endothelial Reactivity, Indexes of Non-Alcoholic Fatty Liver Disease and Systemic Inflammation in Healthy Subjects with Polygenic Hypercholesterolemia: The ANEMONE Study. Nutrients 14 (10) (2022)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Antonio Di Micoli, Maddalena Veronesi, Claudio Borghi
Noninvasive instrumental evaluation of coenzyme Q 10 phytosome on endothelial reactivity in healthy nonsmoking young volunteers: A double-blind, randomized, placebo-controlled crossover clinical trial. BioFactors (Oxford, England) 48 (5) (2022)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Elisabetta Rizzoli, Sergio D'Addato, Claudio Borghi, null null
Correction: Cicero et al. Long-Term Impact of Different Triple Combination Antihypertensive Medications on Blood Pressure Control, Metabolic Pattern and Incident Events: Data from the Brisighella Heart Study. J. Clin. Med. 2021, 10 , 5921. Journal of clinical medicine 11 (23) (2022)
Federica Fogacci, Claudio Borghi, Arrigo F G Cicero
New evidences on the association between high-density lipoprotein cholesterol and cardiovascular risk: a never ending research story. European journal of preventive cardiology 29 (5) (2022)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Claudio Borghi
Vitamin D Supplementation and COVID-19 Outcomes: Mounting Evidence and Fewer Doubts. Nutrients 14 (17) (2022)
Yajnavalka Banerjee, Anca Pantea Stoian, Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Dragana Nikolic, Alexandros Sachinidis, Ali A Rizvi, Andrej Janez, Manfredi Rizzo
Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia. Expert opinion on drug safety (2021)
Pierangelo Coppola, Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Sergio D'Addato, Stefano Bacchelli, Claudio Borghi, null On Behalf Of The Brisighella Heart Study Group
Laboratory and Instrumental Risk Factors Associated with a Sudden Cardiac Death Prone ECG Pattern in the General Population: Data from the Brisighella Heart Study. Journal of clinical medicine 10 (4) (2021)
Federica Fogacci, Claudio Borghi, Arrigo Francesco Giuseppe Cicero
Diets, Foods and Food Components' Effect on Dyslipidemia. Nutrients 13 (3) (2021)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Ivan Cincione
Evaluating pharmacokinetics of bempedoic acid in the treatment of hypercholesterolemia. Expert opinion on drug metabolism & toxicology 17 (9) (2021)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Masanari Kuwabara, Claudio Borghi
Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update. Medicina (Kaunas, Lithuania) 57 (1) (2021)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Elisabetta Rizzoli, Sergio D'Addato, Claudio Borghi
Long-Term Impact of Different Triple Combination Antihypertensive Medications on Blood Pressure Control, Metabolic Pattern and Incident Events: Data from the Brisighella Heart Study. Journal of clinical medicine 10 (24) (2021)
Silvia Fogacci, Federica Fogacci, Elda Favari, Peter P Toth, Claudio Borghi, Arrigo Francesco Giuseppe Cicero
Management of pregnancy-related hypertensive disorders in patients infected with SARS CoV-2: pharmacological and clinical issues. European heart journal. Cardiovascular pharmacotherapy 7 (4) (2021)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Marina Giovannini, Martina Mezzadri, Elisa Grandi, Claudio Borghi, null The Brisighella Heart Study Group
COVID-19-Related Quarantine Effect on Dietary Habits in a Northern Italian Rural Population: Data from the Brisighella Heart Study. Nutrients 13 (2) (2021)
Federica Fogacci, Claudio Borghi, Antonio Di Micoli, Arrigo Francesco Giuseppe Cicero
Sudden Fall in the Lipid-Lowering Effect of Evolocumab: The Butler Is Not Always Guilty. Medicina (Kaunas, Lithuania) 57 (8) (2021)
Arrigo Francesco Giuseppe Cicero, Cormac Kennedy, Tamara Knežević, Marilisa Bove, Coralie M G Georges, Agnė Šatrauskienė, Peter P Toth, Federica Fogacci
Efficacy and Safety of Armolipid Plus®: An Updated PRISMA Compliant Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials. Nutrients 13 (2) (2021)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Maddalena Veronesi, Enrico Strocchi, Elisa Grandi, Elisabetta Rizzoli, Andrea Poli, Franca Marangoni, Claudio Borghi
A randomized Placebo-Controlled Clinical Trial to Evaluate the Medium-Term Effects of Oat Fibers on Human Health: The Beta-Glucan Effects on Lipid Profile, Glycemia and inTestinal Health (BELT) Study. Nutrients 12 (3) (2020)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Adrian V Hernandez, Maciej Banach, null null
Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis. PLoS medicine 17 (7) (2020)
Federica Fogacci, Enrico Strocchi, Maddalena Veronesi, Claudio Borghi, Arrigo Francesco Giuseppe Cicero
Effect of Omega-3 Polyunsaturated Fatty Acids Treatment on Lipid Pattern of HIV Patients: A Meta-Analysis of Randomized Clinical Trials. Marine drugs 18 (6) (2020)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Elisa Grandi, Elisabetta Rizzoli, Marilisa Bove, Sergio D'Addato, Claudio Borghi
Prevalent Seasoning and Cooking Fats, Arterial Stiffness and Blood Lipid Pattern in a Rural Population Sample: Data from the Brisighella Heart Study. Nutrients 12 (10) (2020)
Larysa Strilchuk, Giuliano Tocci, Federica Fogacci, Arrigo Francesco Giuseppe Cicero
An overview of rosuvastatin/ezetimibe association for the treatment of hypercholesterolemia and mixed dyslipidemia. Expert opinion on pharmacotherapy 21 (5) (2020)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Claudio Borghi
Uric acid and thrombotic risk: an emerging link. Internal and emergency medicine 15 (7) (2020)
Arrigo Francesco Giuseppe Cicero, Nicolò Girolimetto, Crescenzio Bentivenga, Elisa Grandi, Federica Fogacci, Claudio Borghi
Short-Term Effect of a New Oral Sodium Hyaluronate Formulation on Knee Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. Diseases (Basel, Switzerland) 8 (3) (2020)
Federica Fogacci, Silvia Fogacci, Arrigo Cicero
Resveratrol for High Blood Pressure: A Total Failure or the Need to Identify the Right Patient? High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 26 (5) (2019)
Federica Fogacci, Giuliano Tocci, Amir Hossein Sahebkar, Vivianne Presta, Maciej Banach, Arrigo Francesco Giuseppe Cicero
Effect of Pycnogenol on Blood Pressure: Findings From a PRISMA Compliant Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled, Clinical Studies. Angiology 71 (3) (2019)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Giovambattista Desideri, Elisa Grandi, Elisabetta Rizzoli, Sergio D'Addato, Claudio Borghi
Arterial Stiffness, Sugar-Sweetened Beverages and Fruits Intake in a Rural Population Sample: Data from the Brisighella Heart Study. Nutrients 11 (11) (2019)
Federica Fogacci, Davide Grassi, Manfredi Rizzo, Arrigo Francesco Giuseppe Cicero
Metabolic effect of berberine-silymarin association: A meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Phytotherapy research : PTR 33 (4) (2019)
Larysa Strilchuk, Federica Fogacci, Arrigo Francesco Giuseppe Cicero
Safety and tolerability of injectable lipid-lowering drugs: an update of clinical data. Expert opinion on drug safety 18 (7) (2019)
Larysa Strilchuk, Federica Fogacci, Arrigo Francesco Giuseppe Cicero
Safety and tolerability of available urate-lowering drugs: a critical review. Expert opinion on drug safety 18 (4) (2019)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Marilisa Bove, Marina Giovannini, Claudio Borghi
Three-arm, placebo-controlled, randomized clinical trial evaluating the metabolic effect of a combined nutraceutical containing a bergamot standardized flavonoid extract in dyslipidemic overweight subjects. Phytotherapy research : PTR 33 (8) (2019)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Maddalena Veronesi, Elisa Grandi, Giovanni Dinelli, Silvana Hrelia, Claudio Borghi
Short-Term Hemodynamic Effects of Modern Wheat Products Substitution in Diet with Ancient Wheat Products: A Cross-Over, Randomized Clinical Trial. Nutrients 10 (11) (2018)
Federica Fogacci, Maciej Banach, Arrigo Francesco Giuseppe Cicero
Resveratrol effect on patients with non-alcoholic fatty liver disease: A matter of dose and treatment length. Diabetes, obesity & metabolism 20 (7) (2018)
Federica Fogacci, Giuliano Tocci, Vivianne Presta, Andrea Fratter, Claudio Borghi, Arrigo Francesco Giuseppe Cicero
Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials. Critical reviews in food science and nutrition 59 (10) (2018)
Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Marina Giovannini, Elisa Grandi, Martina Rosticci, Sergio D'Addato, Claudio Borghi
Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study. Scientific reports 8 (1) (2018)
Chiara Ricci, Massimiliano Ruscica, Marina Camera, Laura Rossetti, Chiara Macchi, Alessandra Colciago, Ilaria Zanotti, Maria Giovanna Lupo, Maria Pia Adorni, Arrigo F G Cicero, Federica Fogacci, Alberto Corsini, Nicola Ferri
PCSK9 induces a pro-inflammatory response in macrophages. Scientific reports 8 (1) (2018)
Marilisa Bove, Federica Fogacci, Arrigo Francesco Giuseppe Cicero
Pharmacokinetic drug evaluation of ezetimibe + simvastatin for the treatment of hypercholesterolemia. Expert opinion on drug metabolism & toxicology 13 (10) (2017)